Re: P/E 10; strong balance sheet We all know the market is incredibly rogue, corrupt and a short sellers dream.BTW how many of you have notified the FCA's market abuse and intelligence teams regarding this share and the SP movements?
Re: P/E 10; strong balance sheet I thought this morning's news was positive, and a broker update had a target price about 50% up from here, but when the market is out of love with a share.......
P/E 10; strong balance sheet Trading on a P/E of just 10 nowAgree with most of the comments on here that the fall is absurd and way overdone.Great assets and balance sheet.Global company.Making gross annual profit of $1BnA flat/1% reduction in total revenue and stable profits vs 2016 should not equate to a >60% fall in the share price!
digital look [link]
DIR. BUYS I have been lucky and in 50yrs of 70% of the time buying purely on director dealing have made money but this is one of my worst purchases ever considering the millions dir. spentWe have 4 broker down grades & 1 buyer saying fall over done just holding on good luck all
ii data I dropped a line to ii about the results table in the fundamentals being in the wrong currency. They responded with thanks and said they would get their software contractor on to it.
Re: RNS: Absurd reaction Agree with most of the comments. Injectables is their largest business is doing well. Branded has got a bit of a forex headwind, and these things happen with international businesses, but usually what is a headwind one year is a tailwind the next. Generics is the main problem area; but it is still profitable (albeit just) and there are some potential juicy new product launches in the offing. Going back to March (its recent high) the company was probably valued as too much of a growth business; and some of the fall in the share price is a reasonable re-rating; but things don't look bad. Numis issuing a cautious buy & Deutsche Bank buying recently are good signs; and maybe all those stop losses being triggered today, may be finding their way to a thankful buyer.
Re: RNS: Absurd reaction SP has halved over 6 months. This is not an over-reaction, it is a recognition that there is a fundamental problem.********** ********** ********** ********** ********** ********** ********** ********** ********** ********** ***What's the 'fundamental problem', personally, I can't see it. Company just hasn't grown its revenues/profit as people had come to expect. As I said earlier, the company is trading at 2016 levels.........it's not as if it's making a loss!!Spike down today definitely caused by stop losses triggering, leading to a 5% gain on the day from the 10% bottom. Although I'm down on the stock, at least managed a long 48pt spreadbet during the course of the day
Re: RNS: Absurd reaction Wow - so negative. This was hardly a profit warning. Sure generics are under pressure, but the other parts of the business are holding up well - despite the Egyptian pound falling. As for a dead cat bounce, you are surely not suggesting Hikma is any trouble. Can I quote the penultimate sentence of the T/A . . . The Group continues to generate good cash flow and has a strong balance sheet, which provides strategic and financial flexibility. Finally, I note Numis now have issued a (cautious) buy note with a target of 1300p.Anyway, I am not complaining - managed to top up again at a good price.
Re: RNS: Absurd reaction SP has halved over 6 months. This is not an over-reaction, it is a recognition that there is a fundamental problem. Yes , there may be a dead cat bounce tomorrow or Monday but it is all too risky for ordinary investors
Re: RNS: Absurd reaction And another thing. I have just noticed on L2 that almost all trades today have been automatic - I am presuming stop losses triggering. When the analysts give this the once over again on fundamentals I think we will see a good SP recovery.
RNS: Absurd reaction I really don't understand. Injectables on a high, branded doing OK and generics a little further down. Result more or less the same. This is a well balanced stock with more to its operation than generics. There is no justification for the fall in SP, so I am topping up!
Re: Thursday More of a toad out of the hat than a rabbit.....Seems like there's an expectation to fail around this stock at the moment. Continuing downward trend regardless and 7% drop this morning on nothing really unexpected.Interesting to note the comment that revenue and operating profit expected to be around 2016 levels. We were at around 1700p then and rising.......now around the 975 mark........
Re: Thursday Yes Paul, That's more or less the point I was trying to make. Another red day today, they really do need to pull a rabbit out of the hat tomorrow. At least Deutsche Bank think it's good value at these prices.
Re: Thursday When i bought @ £25 Y. 0.3% !! it is an income stock now